The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Four years on, long covid still confounds us. Here’s what we now know.
By Frances Stead Sellers
The Washington Post
Updated December 31, 2023
https://www.washingtonpost.com/health/2023/12/31/long-covid-symptoms-treatment-research/
New Research Aims to Unravel Both ME/CFS and Long COVID
Miriam E. Tucker
December 21, 2023
https://www.medscape.com/viewarticle/new-research-aims-unravel-both-me-cfs-and-long-covid-2023a1000w9b
Bethesda, MD — New research into the mechanisms underlying myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and long COVID is aimed at identifying potential approaches to treatment of the two overlapping illnesses.
“I Finally Got My Life Back!” — How One Women Found Relief for Long COVID Fatigue
Research: COVID can cause brain changes that trigger tiredness
By Gina Roberts-Grey and Melissa Gotthardt Updated: March 24, 2024
First For Women
https://www.firstforwomen.com/posts/health/long-covid-fatigue
Are long COVID sufferers being ignored?
Implications of COVID-19 absences for employees.
31 Mar, 2024
Dr. Prajakta Banik
Tech Explorist
https://www.techexplorist.com/long-covid-sufferers-ignored/82594/
Understanding long COVID: A call for better diagnosis and treatment
By Vijay Kumar MalesuMar 7 2024
Reviewed by Susha Cheriyedath, M.Sc.
https://www.news-medical.net/news/20240307/Understanding-long-COVID-A-call-for-better-diagnosis-and-treatment.aspx
Are long COVID sufferers falling through the cracks?
Author Beth Duff-Brown
Published on March 27, 2024
Scopeblog, Stanford Medicine
https://scopeblog.stanford.edu/2024/03/27/long-covid-symptoms-sufferers-misdiagnosed/
AgelessRx Initiates Study on LDN and NAD+ as a Treatment for Long COVID Sufferers
PRESS RELEASE
Published March 27, 2024
Digital Journal
Could Long Covid Be the Senate’s Bipartisan Cause?
Feb. 18, 2024
By Zeynep Tufekci, Opinion Columnist, New York Times
https://www.nytimes.com/2024/02/18/opinion/long-covid-research-funding.html
Low-dose naltrexone and NAD+ for the treatment of patients with persistent fatigue symptoms after COVID-19
Anar Isman, Andy Nyquist, Bailey Strecker, Girish Harinath, Virginia Lee, Xingyu Zhang, Sajad Zalzala
Brain Behav Immun Health, 2024 Feb 1:36:100733. https://pubmed.ncbi.nlm.nih.gov/38352659/
Low-Dose Naltrexone Improves post-COVID-19 Condition Symptoms
Leonardo Tamariz, Elizabeth Bast, Nancy Klimas, Ana Palacio
Clin Ther, . 23rd Jan 2024:S0149-2918(24)00003-1. https://pubmed.ncbi.nlm.nih.gov/38267326/
Abstract
Purpose: Treatments for myalgic encephalomyelitis and chronic fatigue syndrome can be adapted for post-COVID-19 condition. Our aim was to compare treatments in patients from our post-COVID-19 clinic.